China Biologics and Biosimilars Market Research Report 2016

Market: Pharmaceuticals

, 123 pages report, published by QYResearch

Report ThumbnailOctober-2016
Notes:
Sales, means the sales volume of Biologics and Biosimilars
Revenue, means the sales value of Biologics and Biosimilars

This report studies Biologics and Biosimilars in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun high tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
3sbio
Changchun high tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Classification by Technology
Classification by Types
Classification by Use
Classification by Services
Split by Application, this report focuses on consumption, market share and growth rate of Biologics and Biosimilars in each application, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

  • List of Tables and Figures
  • Figure Picture of Biologics and Biosimilars
  • Figure China Production Market Share of Biologics and Biosimilars by Type in 2015
  • Figure Product Picture of Classification by Technology
  • Table Major Manufacturers of Classification by Technology
  • Figure Product Picture of Classification by Types
  • Table Major Manufacturers of Classification by Types
  • Figure Product Picture of Classification by Use
  • Table Major Manufacturers of Classification by Use
  • Figure Product Picture of Classification by Services
  • Table Major Manufacturers of Classification by Services
  • Table Biologics and Biosimilars Consumption Market Share by Application in 2015
  • Figure Tumor Examples
  • Figure Diabetes Examples
  • Figure Cardiovascular Examples
  • Figure Hemophilia Examples
  • Figure Other Examples
  • Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
  • Table China Biologics and Biosimilars Capacity of Key Manufacturers (2015 and 2016)
  • Table China Biologics and Biosimilars Capacity Market Share of Key Manufacturers (2015 and 2016)
  • Figure China Biologics and Biosimilars Capacity of Key Manufacturers in 2015
  • Figure China Biologics and Biosimilars Capacity of Key Manufacturers in 2016
  • Table China Biologics and Biosimilars Production of Key Manufacturers (2015 and 2016)
  • Table China Biologics and Biosimilars Production Share by Manufacturers (2015 and 2016)
  • Figure 2015 Biologics and Biosimilars Production Share by Manufacturers
  • Figure 2016 Biologics and Biosimilars Production Share by Manufacturers
  • Table China Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
  • Table China Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
  • Table 2015 China Biologics and Biosimilars Revenue Share by Manufacturers
  • Table 2016 China Biologics and Biosimilars Revenue Share by Manufacturers
  • Table China Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)
  • Figure China Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015
  • Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area
  • Table Manufacturers Biologics and Biosimilars Product Type
  • Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
  • Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
  • Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Pfizer Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Pfizer Biologics and Biosimilars Market Share (2011-2016)
  • Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Roche Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Roche Biologics and Biosimilars Market Share (2011-2016)
  • Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Amgen Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Amgen Biologics and Biosimilars Market Share (2011-2016)
  • Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table AbbVie Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure AbbVie Biologics and Biosimilars Market Share (2011-2016)
  • Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Sanofi Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Sanofi Biologics and Biosimilars Market Share (2011-2016)
  • Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Johnson & Johnson Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Johnson & Johnson Biologics and Biosimilars Market Share (2011-2016)
  • Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Novo Nordisk Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Novo Nordisk Biologics and Biosimilars Market Share (2011-2016)
  • Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Novartis Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Novartis Biologics and Biosimilars Market Share (2011-2016)
  • Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Merck Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Merck Biologics and Biosimilars Market Share (2011-2016)
  • Table Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Lilly Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Lilly Biologics and Biosimilars Market Share (2011-2016)
  • Table 3sbio Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table 3sbio Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure 3sbio Biologics and Biosimilars Market Share (2011-2016)
  • Table Changchun high tech Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Changchun high tech Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Changchun high tech Biologics and Biosimilars Market Share (2011-2016)
  • Table CP Guojian Pharmacy Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table CP Guojian Pharmacy Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure CP Guojian Pharmacy Biologics and Biosimilars Market Share (2011-2016)
  • Table Biotech Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Biotech Pharma Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Biotech Pharma Biologics and Biosimilars Market Share (2011-2016)
  • Table Gelgen Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Gelgen Biopharma Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Gelgen Biopharma Biologics and Biosimilars Market Share (2011-2016)
  • Table Sandoz Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Sandoz Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Sandoz Biologics and Biosimilars Market Share (2011-2016)
  • Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Teva Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Teva Biologics and Biosimilars Market Share (2011-2016)
  • Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Hospira Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Hospira Biologics and Biosimilars Market Share (2011-2016)
  • Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Mylan Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Mylan Biologics and Biosimilars Market Share (2011-2016)
  • Table 3sbio Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table 3sbio Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure 3sbio Biologics and Biosimilars Market Share (2011-2016)
  • Table Changchun high tech Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Changchun high tech Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Changchun high tech Biologics and Biosimilars Market Share (2011-2016)
  • Table CP Guojian Pharmacy Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table CP Guojian Pharmacy Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure CP Guojian Pharmacy Biologics and Biosimilars Market Share (2011-2016)
  • Table Biotech Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Biotech Pharma Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Biotech Pharma Biologics and Biosimilars Market Share (2011-2016)
  • Table Gelgen Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Gelgen Biopharma Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Gelgen Biopharma Biologics and Biosimilars Market Share (2011-2016)
  • Figure China Biologics and Biosimilars Capacity, Production and Growth (2011-2016)
  • Figure China Biologics and Biosimilars Revenue (Million USD) and Growth (2011-2016)
  • Table China Biologics and Biosimilars Production, Consumption, Export and Import (2011-2016)
  • Table China Biologics and Biosimilars Production by Type (2011-2016)
  • Table China Biologics and Biosimilars Production Share by Type (2011-2016)
  • Figure Production Market Share of Biologics and Biosimilars by Type (2011-2016)
  • Figure 2015 Production Market Share of Biologics and Biosimilars by Type
  • Table China Biologics and Biosimilars Revenue by Type (2011-2016)
  • Table China Biologics and Biosimilars Revenue Share by Type (2011-2016)
  • Figure Production Revenue Share of Biologics and Biosimilars by Type (2011-2016)
  • Figure 2015 Revenue Market Share of Biologics and Biosimilars by Type
  • Table China Biologics and Biosimilars Price by Type (2011-2016)
  • Figure China Biologics and Biosimilars Production Growth by Type (2011-2016)
  • Table China Biologics and Biosimilars Consumption by Application (2011-2016)
  • Table China Biologics and Biosimilars Consumption Market Share by Application (2011-2016)
  • Figure China Biologics and Biosimilars Consumption Market Share by Application in 2015
  • Table China Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)
  • Figure China Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Biologics and Biosimilars
  • Figure Manufacturing Process Analysis of Biologics and Biosimilars
  • Figure Biologics and Biosimilars Industrial Chain Analysis
  • Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
  • Table Major Buyers of Biologics and Biosimilars
  • Table Distributors/Traders List
  • Figure China Biologics and Biosimilars Capacity, Production and Growth Rate Forecast (2016-2021)
  • Figure China Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
  • Table China Biologics and Biosimilars Production, Import, Export and Consumption Forecast (2016-2021)
  • Table China Biologics and Biosimilars Production Forecast by Type (2016-2021)
  • Table China Biologics and Biosimilars Consumption Forecast by Application (2016-2021)
  • Table of Contents
  • China Biologics and Biosimilars Market Research Report 2016
  • 1 Biologics and Biosimilars Market Overview
  • 1.1 Product Overview and Scope of Biologics and Biosimilars
  • 1.2 Biologics and Biosimilars Segment by Type
  • 1.2.1 China Production Market Share of Biologics and Biosimilars Type in 2015
  • 1.2.2 Classification by Technology
  • 1.2.3 Classification by Types
  • 1.2.4 Classification by Use
  • 1.2.5 Classification by Services
  • 1.3 Applications of Biologics and Biosimilars
  • 1.3.1 Biologics and Biosimilars Consumption Market Share by Application in 2015
  • 1.3.2 Tumor
  • 1.3.3 Diabetes
  • 1.3.4 Cardiovascular
  • 1.3.5 Hemophilia
  • 1.3.6 Other
  • 1.4 China Market Size (Value) of Biologics and Biosimilars (2011-2021)
  • 1.5 China Biologics and BiosimilarsStatus and Outlook
  • 1.6 Government Policies
  • 2 China Biologics and Biosimilars Market Competition by Manufacturers
  • 2.1 China Biologics and Biosimilars Capacity, Production and Share by Manufacturers (2015 and 2016)
  • 2.2 China Biologics and Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
  • 2.3 China Biologics and Biosimilars Average Price by Manufacturers (2015 and 2016)
  • 2.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area, Product Type
  • 2.5 Biologics and Biosimilars Market Competitive Situation and Trends
  • 2.5.1 Biologics and Biosimilars Market Concentration Rate
  • 2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
  • 3 China Biologics and Biosimilars Manufacturers Profiles/Analysis
  • 3.1 Pfizer
  • 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.1.2 Biologics and Biosimilars Product Type, Application and Specification
  • 3.1.2.1 Type I
  • 3.1.2.2 Type II
  • 3.1.3 Pfizer Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.1.4 Main Business/Business Overview
  • 3.2 Roche
  • 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.2.2 123 Product Type, Application and Specification
  • 3.2.2.1 Type I
  • 3.2.2.2 Type II
  • 3.2.3 Roche 123 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.2.4 Main Business/Business Overview
  • 3.3 Amgen
  • 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.3.2 127 Product Type, Application and Specification
  • 3.3.2.1 Type I
  • 3.3.2.2 Type II
  • 3.3.3 Amgen 127 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.3.4 Main Business/Business Overview
  • 3.4 AbbVie
  • 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.4.2 Sept Product Type, Application and Specification
  • 3.4.2.1 Type I
  • 3.4.2.2 Type II
  • 3.4.3 AbbVie Sept Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.4.4 Main Business/Business Overview
  • 3.5 Sanofi
  • 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.5.2 Product Type, Application and Specification
  • 3.5.2.1 Type I
  • 3.5.2.2 Type II
  • 3.5.3 Sanofi Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.5.4 Main Business/Business Overview
  • 3.6 Johnson & Johnson
  • 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.6.2 Million USD Product Type, Application and Specification
  • 3.6.2.1 Type I
  • 3.6.2.2 Type II
  • 3.6.3 Johnson & Johnson Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.6.4 Main Business/Business Overview
  • 3.7 Novo Nordisk
  • 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.7.2 Pharmaceuticals Product Type, Application and Specification
  • 3.7.2.1 Type I
  • 3.7.2.2 Type II
  • 3.7.3 Novo Nordisk Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.7.4 Main Business/Business Overview
  • 3.8 Novartis
  • 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.8.2 Product Type, Application and Specification
  • 3.8.2.1 Type I
  • 3.8.2.2 Type II
  • 3.8.3 Novartis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.8.4 Main Business/Business Overview
  • 3.9 Merck
  • 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.9.2 Product Type, Application and Specification
  • 3.9.2.1 Type I
  • 3.9.2.2 Type II
  • 3.9.3 Merck Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.9.4 Main Business/Business Overview
  • 3.10 Lilly
  • 3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.10.2 Product Type, Application and Specification
  • 3.10.2.1 Type I
  • 3.10.2.2 Type II
  • 3.10.3 Lilly Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.10.4 Main Business/Business Overview
  • 3.11 3sbio
  • 3.12 Changchun high tech
  • 3.13 CP Guojian Pharmacy
  • 3.14 Biotech Pharma
  • 3.15 Gelgen Biopharma
  • 3.16 Sandoz
  • 3.17 Teva
  • 3.18 Hospira
  • 3.19 Mylan
  • 3.20 3sbio
  • 3.21 Changchun high tech
  • 3.22 CP Guojian Pharmacy
  • 3.23 Biotech Pharma
  • 3.24 Gelgen Biopharma
  • 4 China Biologics and Biosimilars Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
  • 4.1 China Biologics and Biosimilars Capacity, Production and Growth (2011-2016)
  • 4.2 China Biologics and Biosimilars Revenue and Growth (2011-2016)
  • 4.3 China Biologics and Biosimilars Production, Consumption, Export and Import (2011-2016)
  • 5 China Biologics and Biosimilars Production, Revenue (Value), Price Trend by Type
  • 5.1 China Biologics and Biosimilars Production and Market Share by Type (2011-2016)
  • 5.2 China Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
  • 5.3 China Biologics and Biosimilars Price by Type (2011-2016)
  • 5.4 China Biologics and Biosimilars Production Growth by Type (2011-2016)
  • 6 China Biologics and Biosimilars Market Analysis by Application
  • 6.1 China Biologics and Biosimilars Consumption and Market Share by Application (2011-2016)
  • 6.2 China Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)
  • 6.3 Market Drivers and Opportunities
  • 6.3.1 Potential Application
  • 6.3.2 Emerging Markets/Countries
  • 7 Biologics and Biosimilars Manufacturing Cost Analysis
  • 7.1 Biologics and Biosimilars Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Price Trend of Key Raw Materials
  • 7.1.3 Key Suppliers of Raw Materials
  • 7.1.4 Market Concentration Rate of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.2.1 Raw Materials
  • 7.2.2 Labor Cost
  • 7.2.3 Manufacturing Expenses
  • 7.3 Manufacturing Process Analysis of Biologics and Biosimilars
  • 8 Industrial Chain, Sourcing Strategy and Downstream Buyers
  • 8.1 Biologics and Biosimilars Industrial Chain Analysis
  • 8.2 Upstream Raw Materials Sourcing
  • 8.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
  • 8.4 Downstream Buyers
  • 9 Marketing Strategy Analysis, Distributors/Traders
  • 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
  • 9.1.3 Marketing Channel Development Trend
  • 9.2 Market Positioning
  • 9.2.1 Pricing Strategy
  • 9.2.2 Brand Strategy
  • 9.2.3 Target Client
  • 9.3 Distributors/Traders List
  • 10 Market Effect Factors Analysis
  • 10.1 Technology Progress/Risk
  • 10.1.1 Substitutes Threat
  • 10.1.2 Technology Progress in Related Industry
  • 10.2 Consumer Needs/Customer Preference Change
  • 10.3 Economic/Political Environmental Change
  • 11 China Biologics and Biosimilars Market Forecast (2016-2021)
  • 11.1 China Biologics and Biosimilars Capacity, Production, Revenue Forecast (2016-2021)
  • 11.2 China Biologics and Biosimilars Production, Import, Export and Consumption Forecast (2016-2021)
  • 11.3 China Biologics and Biosimilars Production Forecast by Type (2016-2021)
  • 11.4 China Biologics and Biosimilars Consumption Forecast by Application (2016-2021)
  • 11.5 Biologics and Biosimilars Price Forecast (2016-2021)
  • 12 Research Findings and Conclusion
  • 13 Appendix
  • Author List
  • Disclosure Section
  • Research Methodology
  • Data Source
  • China Disclaimer

Please select a license type

Share

Related Products

QYResearchChina Biologics and Biosimilars Market Research Report 2016 Product ThumbnailChina Biologics and Biosimilars Market Research Report 2016 , Industry ReportProduct #: 571300
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved